(Q37729815)

22 August 2017

1 reference

title

Imaging ovarian cancer and peritoneal metastases--current and emerging techniques (English)

1 reference

22 August 2017

1 reference

Stavroula Kyriazi

1

1 reference

22 August 2017

Stan B Kaye

series ordinal

2

1 reference

22 August 2017

Nandita M deSouza

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

13 April 2010

1 reference

Nature Reviews Clinical Oncology

22 August 2017

published in

1 reference

22 August 2017

volume

7

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

381-393

1 reference

Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Clinical value of positron emission tomography with FDG for recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Influence of 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography on recurrent ovarian cancer diagnosis and on selection of patients for secondary cytoreductive surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

31 March 2020

Carcinoma of the Ovary

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

The peritoneal ligaments and mesenteries: pathways of intraabdominal spread of disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Intraperitoneal cancer dissemination: mechanisms of the patterns of spread

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Multidetector CT of Peritoneal Carcinomatosis from Ovarian Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Peritoneal implants from ovarian tumors: CT findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Serous carcinoma of the ovary: CT identification of metastatic calcified implants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Predictive Value of Percutaneous Imaging-Guided Biopsy of Peritoneal and Omental Masses: Results in 111 Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Peritoneal carcinomatosis: image-guided peritoneal core biopsy for tumor type and patient care

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Peritoneal metastases: detection with spiral CT in patients with ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Evaluation of computed tomography in patients with peritoneal carcinomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Ovarian cancer: comparison of observer performance for four methods of interpreting CT scans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Characterization of adnexal mass lesions on MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

31 March 2020

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Surveillance of patients after initial treatment of ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Ovarian cancer: what's new, where next?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Recurrent ovarian cancer: spectrum of imaging findings.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Cerebral metastasis and other cerebral events in women with ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Supradiaphragmatic manifestations of papillary serous adenocarcinoma of the ovary

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

PET-CT vs. CT alone in ovarian cancer recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Accuracy of computed tomography and magnetic resonance imaging in the detection of lymph node involvement in cervix carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Radioimmunoscintigraphy in patients with ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

The impact of PET/CT in the management of recurrent ovarian cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Characterization of small (≤10 mm) focal liver lesions: value of respiratory-triggered echo-planar diffusion-weighted MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Diffusion-weighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Predicting Response of Colorectal Hepatic Metastasis: Value of Pretreatment Apparent Diffusion Coefficients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Lymph node detection by MRI before and after a systematic pelvic lymphadenectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Diffusion-weighted EPI of cystic ovarian lesions: evaluation of cystic contents using apparent diffusion coefficients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Relationship between apparent diffusion coefficient and signal intensity in endometrial and other pelvic cysts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Diffusion-weighted echo-planar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: usefulness of detecting keratinoid substances in mature cystic teratomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla: technical development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

1H-magnetic resonance spectroscopy: a new technique to discriminate benign from malignant ovarian tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Evaluation of female intrapelvic tumors by clinical proton MR spectroscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Alterations of choline phospholipid metabolism in ovarian tumor progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo1H MR Spectroscopy—A Pilot Study at 4 T

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Monitoring of early response to neoadjuvant chemotherapy in breast cancer with (1)H MR spectroscopy: comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Whole-body diffusion-weighted magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Whole-body MRI for the staging and follow-up of patients with metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Laparoscopic optical coherence tomography imaging of human ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Activatable fluorescent molecular imaging of peritoneal metastases following pretargeting with a biotinylated monoclonal antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

A physiologic imaging pilot study of breast cancer treated with AZD2171.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Apparent diffusion coefficient histograms may predict low-grade glioma subtype.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Kinetic analysis of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.47

Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI

31 March 2020

1 reference

12 December 2020

The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma

1 reference

12 December 2020

Reproducibility of metabolic measurements in malignant tumors using FDG PET

1 reference

12 December 2020

Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display

1 reference

12 December 2020

Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer

1 reference

12 December 2020

Correlation of diffusion-weighted MR imaging with cellularity of renal tumours.

1 reference

12 December 2020

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

1 reference

12 December 2020

1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterization

1 reference

12 December 2020

Peritoneal carcinomatosis: role of (18)F-FDG PET.

1 reference

12 December 2020

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

12 December 2020

Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

1 reference

12 December 2020

10.1038/NRCLINONC.2010.47

Identifiers

DOI

1 reference

22 August 2017

1 reference